Comparison of opioid use disorder among male veterans and non‐veterans: Disorder rates, socio‐demographics, co‐morbidities, and quality of life
Tóm tắt
Amidst a surging national crisis of opioid use, concern has been expressed about its impact on veterans, but no study has presented a population‐based comparison of opioid use disorder (OUD) among veterans and non‐veterans. We analyzed national epidemiologic data to compare rates, correlates and impacts of the opioid crisis on male veterans and non‐veterans.
Restricted data from 2012 to 2013 National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III) were used to compare veteran and non‐veteran men on rates of OUD, as well as correlates of OUD including socio‐demographic characteristics, psychiatric and substance use co‐morbidities, and reductions in health‐related quality of life (HRQOL).
About 2.0% of veterans and 2.7% of non‐veterans, estimated at 418,000 and 2.5 million men, respectively, met criteria for life‐time OUD. In both groups, OUD was associated with younger age, lower income levels, and fewer years of education. OUD was associated minority race among veterans, but with non‐Hispanic white race among non‐veterans. Both veteran and non‐veteran adults with OUD were at least five times more likely than their peers to have both psychiatric and substance use co‐morbidities (
Veterans and non‐veterans experience similar risk of OUD, similar correlates and adverse HRQOL impacts suggesting that similar treatment approaches may be effective for both groups.
Our findings highlight comparable vulnerability of veterans to non‐veterans in both the risk of OUD and adverse effects on HRQOL. (Am J Addict 2018;XX:1–9)
Từ khóa
Tài liệu tham khảo
Centers for Disease Control and Prevention. Drug Overdose Death Data.2017;https://www.cdc.gov/drugoverdose/data/statedeaths.html. Accessed July 3 2018.
Quinnones S, 2016, Dreamland: The True Tale of America's Opiate Epidemic
Sanger‐KatzM. Bleak New Estimates in Drug Epidemic: A Record 72 000 Overdose Deaths in 2017.The New York Times2018.https://www.nytimes.com/2018/08/15/upshot/opioids‐overdose‐deaths‐rising‐fentanyl.html. Accessed August 15 2018.
GoldbergB. Opioid abuse crisis takes heavy toll on U.S. veterans. 2017;https://www.reuters.com/article/us‐usa‐veterans‐opioids/opioid‐abuse‐crisis‐takes‐heavy‐toll‐on‐u‐s‐veterans‐idUSKBN1DA1B2. Accessed August 31 2018.
Center for Ethics and the Role of Law. The Intersection of Opioid Overuse and Veteran Mental Health Challenges.2017;https://www.law.upenn.edu/live/files/6192‐cerl‐report‐on‐ptsd‐and‐opioid‐addiction‐final.
National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III). 2017;https://www.niaaa.nih.gov/research/nesarc‐iii. Accessed August 15 2018.
National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III): Source and accuracy statement. 2018;https://www.niaaa.nih.gov/sites/default/files/NESARC_Final_Report_FINAL_1_8_15.pdf. Accessed August 15 2018.
U.S. Department of Veterans Affairs. National Center for Veterans Analysis and Statistics. 2018;https://www.va.gov/VETDATA/Veteran_Population.asp. Accessed August 16 2018.
Cohen J, 1988, Statistical Power Analysis for the Behavioral Sciences
Stata Statistical Software: Release 15 [computer program]. College Station TX: StataCorp LP. 2017.
Substance Abuse Mental Health Services Administration. CBHSQ Data review: Prevalence of past year substance use and mental illness by veteran status in a nationally representative sample. 2016;https://www.samhsa.gov/data/sites/default/files/NSDUH‐DR‐VeteranTrends‐2016/NSDUH‐DR‐VeteranTrends‐2016.pdf. Accessed August 21 2018.
Mattick RP, 2014, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev, 6, CD002207
Mattick RP, 2009, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database Syst Rev, 8, CD002209
Gowing L, 2017, Buprenorphine for managing opioid withdrawal, Cochrane Database Syst Rev, 2, CD002025